Loncar Cancer Immunotherapy ETF
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Loncar Cancer Immunotherapy ETF COM, CUSIP 26922a826.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Loncar Cancer Immunotherapy ETF COM, CUSIP 26922a826.